PATENT CLAIM ANALYSIS

Application Number: 15924952
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "315000"]

Abstract:
Provided are compounds and pharmaceutically acceptable salts thereof, and combinations of compounds, their pharmaceutical compositions, their methods of preparation, and methods for their use in treating or preventing infectious disease.

Claim (Index 17):
The method according to  claim 16 , wherein the respiratory infectious disease is influenza.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 90.0
- Lexical Diversity: 1.4
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11738148', '15052631', '15034583', '14142666', '14783911']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7995583470822321
- 35 USC 102 Novelty (BERT): 0.5045419336644206
- Combined Prediction Score: 0.7700567057404509
- Mean Citation Score: 245.788388
- Max Citation Score: 260.67398
- Similarity Product: 187.2591137998485

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test